PMID- 16442912 OWN - NLM STAT- MEDLINE DCOM- 20060210 LR - 20220321 IS - 1097-6744 (Electronic) IS - 0002-8703 (Print) IS - 0002-8703 (Linking) VI - 151 IP - 2 DP - 2006 Feb TI - Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. PG - 444-50 AB - BACKGROUND: The association between higher New York Heart Association (NYHA) class and outcomes in patients with heart failure and preserved systolic function is not well known. METHODS: We performed a retrospective follow-up study of 988 patients with heart failure with ejection fraction > 45% who participated in the DIG trial. Using Cox proportional hazard models, we estimated risks and all-cause mortality, heart failure mortality, all-cause hospitalization, and hospitalization due to worsening heart failure during a median follow-up of 38.5 months. RESULTS: Patients had a median age of 68 years; 41.2% were women and 13.9%, nonwhites. Overall, 23.4% of patients died, and 19.9% were hospitalized because of worsening heart failure. Proportion of patients with NYHA classes I, II, III, and IV were 19.9%, 58.0%, 20.9%, and 1.2%, respectively, and 14.7%, 21.1%, 35.9%, and 58.3%, respectively, died of all causes (P < .001 for trend). Respective rates for heart failure-related hospitalizations were 14.2%, 17.1%, 32.5%, and 33.3% (P < .001 for trend). Compared with NYHA class I patients, adjusted hazard ratios (HRs) for all-cause mortality for class II, III, and IV patients were 1.54 (95% CI 1.02-2.32, P = .042), 2.56 (95% CI 1.64-24.01, P < .001), and 8.46 (95% CI 3.57-20.03, P < .001), respectively. Respective adjusted HRs (95% CI) for hospitalization due to heart failure for class II, III, and IV patients were 1.16 (0.76-1.77) (P = .502), 2.27 (1.45-3.56) (P < .001), and 3.71 (1.25-11.02) (P = 018). New York Heart Association classes II through IV were also associated with higher risk of all-cause hospitalization. CONCLUSION: Higher NYHA classes were associated with poorer outcomes in patients with heart failure and preserved systolic function. FAU - Ahmed, Ali AU - Ahmed A AD - Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Alabama, Birmingham, AL, USA. aahmed@uab.edu FAU - Aronow, Wilbert S AU - Aronow WS FAU - Fleg, Jerome L AU - Fleg JL LA - eng GR - K23 AG019211/AG/NIA NIH HHS/United States GR - K23 AG019211-02/AG/NIA NIH HHS/United States GR - K23 AG019211-03/AG/NIA NIH HHS/United States GR - 1-K23-AG19211-01/AG/NIA NIH HHS/United States PT - Journal Article PT - Multicenter Study PT - Research Support, N.I.H., Extramural PL - United States TA - Am Heart J JT - American heart journal JID - 0370465 RN - 0 (Cardiotonic Agents) RN - 73K4184T59 (Digoxin) SB - IM MH - Aged MH - Cardiotonic Agents/therapeutic use MH - Cause of Death MH - Diabetes Complications/mortality MH - Digoxin/therapeutic use MH - Female MH - Heart Failure/*classification/drug therapy/*mortality/physiopathology MH - Hospitalization MH - Humans MH - Kidney Diseases/complications MH - Male MH - Proportional Hazards Models MH - Randomized Controlled Trials as Topic MH - Retrospective Studies MH - *Severity of Illness Index MH - Statistics, Nonparametric MH - *Stroke Volume PMC - PMC2771182 MID - NIHMS78002 EDAT- 2006/01/31 09:00 MHDA- 2006/02/14 09:00 PMCR- 2009/11/01 CRDT- 2006/01/31 09:00 PHST- 2004/11/01 00:00 [received] PHST- 2005/03/26 00:00 [accepted] PHST- 2006/01/31 09:00 [pubmed] PHST- 2006/02/14 09:00 [medline] PHST- 2006/01/31 09:00 [entrez] PHST- 2009/11/01 00:00 [pmc-release] AID - S0002-8703(05)00521-1 [pii] AID - 10.1016/j.ahj.2005.03.066 [doi] PST - ppublish SO - Am Heart J. 2006 Feb;151(2):444-50. doi: 10.1016/j.ahj.2005.03.066.